536 related articles for article (PubMed ID: 1352034)
1. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
2. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
3. Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.
Clarke WP; Yocca FD; Maayani S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1259-66. PubMed ID: 8667186
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
6. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors.
Kawai N; Yamamoto T; Baba A; Yamamoto H; Moroji T
Arzneimittelforschung; 1994 Jan; 44(1):1-3. PubMed ID: 7907870
[TBL] [Abstract][Full Text] [Related]
8. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
Newman ME; Shapira B; Lerer B
J Pharmacol Exp Ther; 1992 Jan; 260(1):16-20. PubMed ID: 1530973
[TBL] [Abstract][Full Text] [Related]
11. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
12. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
14. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones.
Meller E; Bohmaker K
J Pharmacol Exp Ther; 1994 Dec; 271(3):1246-52. PubMed ID: 7996433
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
16. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
17. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
18. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
Adrien J; Lanfumey L; Gozlan H; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1222-30. PubMed ID: 2522986
[TBL] [Abstract][Full Text] [Related]
20. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
